최소 단어 이상 선택하여야 합니다.
최대 10 단어까지만 선택 가능합니다.
다음과 같은 기능을 한번의 로그인으로 사용 할 수 있습니다.
NTIS 바로가기Biomedicines, v.10 no.5, 2022년, pp.1170 -
Jin, Young-Hee (KM Application Center, Korea Institute of Oriental Medicine, Daegu 41062, Korea) , Lee, Jihye (Zoonotic Virus Laboratory, Institut Pasteur Korea, Seongnam 13488, Korea) , Jeon, Sangeun (jihye.lee_01@ip-korea.org (J.L.)) , Kim, Seungtaek (sangeun.jeon@ip-korea.org (S.J.)) , Min, Jung Sun (seungtaek.kim@ip-korea.org (S.K.)) , Kwon, Sunoh (Zoonotic Virus Laboratory, Institut Pasteur Korea, Seongnam 13488, Korea)
The natural plant dietary polyphenols 1,2,3,4,6-O-Pentagalloylglucose (PGG) and proanthocyanidin (PAC) have potent antioxidant activity and a variety of pharmacological activities, including antiviral activity. In this study, we examined the inhibitory effect of PGG and PAC on SARS-CoV-2 virus infec...
1. V’Kovski P. Kratzel A. Steiner S. Stalder H. Thiel V. Coronavirus biology and replication: Implications for SARS-CoV-2 Nat. Rev. Microbiol. 2021 19 155 170 10.1038/s41579-020-00468-6 33116300
2. World Health Organization WHO Coronavirus (COVID-19) Dashboard Available online: https://covid19.who.int/ (accessed on 11 April 2022)
3. Krause P.R. Fleming T.R. Longini I.M. Peto R. Briand S. Heymann D.L. Beral V. Snape M.D. Rees H. Ropero A.M. SARS-CoV-2 Variants and Vaccines N. Engl. J. Med. 2021 385 179 186 10.1056/NEJMsr2105280 34161052
4. Hu B. Guo H. Zhou P. Shi Z.L. Characteristics of SARS-CoV-2 and COVID-19 Nat. Rev. Microbiol. 2021 19 141 154 10.1038/s41579-020-00459-7 33024307
5. Hattori S.I. Higashi-Kuwata N. Hayashi H. Allu S.R. Raghavaiah J. Bulut H. Das D. Anson B.J. Lendy E.K. Takamatsu Y. A small molecule compound with an indole moiety inhibits the main protease of SARS-CoV-2 and blocks virus replication Nat. Commun. 2021 12 668 10.1038/s41467-021-20900-6 33510133
6. Picarazzi F. Vicenti I. Saladini F. Zazzi M. Mori M. Targeting the RdRp of Emerging RNA Viruses: The Structure-Based Drug Design Challenge Molecules 2020 25 5695 10.3390/molecules25235695
7. Vuong W. Khan M.B. Fischer C. Arutyunova E. Lamer T. Shields J. Saffran H.A. McKay R.T. van Belkum M.J. Joyce M.A. Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication Nat. Commun. 2020 11 4282 10.1038/s41467-020-18096-2 32855413
8. Sheahan T.P. Sims A.C. Zhou S. Graham R.L. Pruijssers A.J. Agostini M.L. Leist S.R. Schafer A. Dinnon K.H. 3rd Stevens L.J. An orally bioavailable broad-spectrum antiviral inhibits SARS-CoV-2 in human airway epithelial cell cultures and multiple coronaviruses in mice Sci. Transl. Med. 2020 12 eabb5883 10.1126/scitranslmed.abb5883 32253226
9. Owen D.R. Allerton C.M.N. Anderson A.S. Aschenbrenner L. Avery M. Berritt S. Boras B. Cardin R.D. Carlo A. Coffman K.J. An oral SARS-CoV-2 M(pro) inhibitor clinical candidate for the treatment of COVID-19 Science 2021 374 1586 1593 10.1126/science.abl4784 34726479
10. Yin W. Mao C. Luan X. Shen D.D. Shen Q. Su H. Wang X. Zhou F. Zhao W. Gao M. Structural basis for inhibition of the RNA-dependent RNA polymerase from SARS-CoV-2 by remdesivir Science 2020 368 1499 1504 10.1126/science.abc1560 32358203
11. Bors W. Michel C. Stettmaier K. Electron paramagnetic resonance studies of radical species of proanthocyanidins and gallate esters Arch. Biochem. Biophys. 2000 374 347 355 10.1006/abbi.1999.1606 10666317
12. Bors W. Michel C. Chemistry of the antioxidant effect of polyphenols Ann. N. Y. Acad. Sci. 2002 957 57 69 10.1111/j.1749-6632.2002.tb02905.x 12074961
13. Abdelwahed A. Bouhlel I. Skandrani I. Valenti K. Kadri M. Guiraud P. Steiman R. Mariotte A.M. Ghedira K. Laporte F. Study of antimutagenic and antioxidant activities of gallic acid and 1,2,3,4,6-pentagalloylglucose from Pistacia lentiscus: Confirmation by microarray expression profiling Chem. Biol. Interact. 2007 165 1 13 10.1016/j.cbi.2006.10.003 17129579
14. Kang D.G. Moon M.K. Choi D.H. Lee J.K. Kwon T.O. Lee H.S. Vasodilatory and anti-inflammatory effects of the 1,2,3,4,6-penta-O-galloyl-beta-D-glucose (PGG) via a nitric oxide-cGMP pathway Eur. J. Pharmacol. 2005 524 111 119 10.1016/j.ejphar.2005.08.061 16253226
16. Li Y. Kim J. Li J. Liu F. Liu X. Himmeldirk K. Ren Y. Wagner T.E. Chen X. Natural anti-diabetic compound 1,2,3,4,6-penta-O-galloyl-D-glucopyranose binds to insulin receptor and activates insulin-mediated glucose transport signaling pathway Biochem. Biophys. Res. Commun. 2005 336 430 437 10.1016/j.bbrc.2005.08.103 16137651
17. Park E.J. Zhao Y.Z. An R.B. Kim Y.C. Sohn D.H. 1,2,3,4,6-penta-O-galloyl-beta-D-glucose from Galla Rhois protects primary rat hepatocytes from necrosis and apoptosis Planta Med. 2008 74 1380 1383 10.1055/s-2008-1081300 18622905
18. Fujiwara H. Tabuchi M. Yamaguchi T. Iwasaki K. Furukawa K. Sekiguchi K. Ikarashi Y. Kudo Y. Higuchi M. Saido T.C. A traditional medicinal herb Paeonia suffruticosa and its active constituent 1,2,3,4,6-penta-O-galloyl-beta-D-glucopyranose have potent anti-aggregation effects on Alzheimer’s amyloid beta proteins in vitro and in vivo J. Neurochem. 2009 109 1648 1657 10.1111/j.1471-4159.2009.06069.x 19457098
19. Ahn M.J. Kim C.Y. Lee J.S. Kim T.G. Kim S.H. Lee C.K. Lee B.B. Shin C.G. Huh H. Kim J. Inhibition of HIV-1 integrase by galloyl glucoses from Terminalia chebula and flavonol glycoside gallates from Euphorbia pekinensis Planta Med. 2002 68 457 459 10.1055/s-2002-32070 12058327
20. Liu G. Xiong S. Xiang Y.F. Guo C.W. Ge F. Yang C.R. Zhang Y.J. Wang Y.F. Kitazato K. Antiviral activity and possible mechanisms of action of pentagalloylglucose (PGG) against influenza A virus Arch. Virol. 2011 156 1359 1369 10.1007/s00705-011-0989-9 21479599
21. Lee S.J. Lee H.K. Jung M.K. Mar W. In vitro antiviral activity of 1,2,3,4,6-penta-O-galloyl-beta-D-glucose against hepatitis B virus Biol. Pharm. Bull. 2006 29 2131 2134 10.1248/bpb.29.2131 17015965
22. Behrendt P. Perin P. Menzel N. Banda D. Pfaender S. Alves M.P. Thiel V. Meuleman P. Colpitts C.C. Schang L.M. Pentagalloylglucose, a highly bioavailable polyphenolic compound present in Cortex moutan, efficiently blocks hepatitis C virus entry Antivir. Res. 2017 147 19 28 10.1016/j.antiviral.2017.09.006 28923507
23. Tu Z. Xu M. Zhang J. Feng Y. Hao Z. Tu C. Liu Y. Pentagalloylglucose Inhibits the Replication of Rabies Virus via Mediation of the miR-455/SOCS3/STAT3/IL-6 Pathway J. Virol. 2019 93 e00539-19 10.1128/JVI.00539-19 31243136
24. Zhang Z. Zheng L. Zhao Z. Shi J. Wang X. Huang J. Grape seed proanthocyanidins inhibit H 2 O 2 -induced osteoblastic MC3T3-E1 cell apoptosis via ameliorating H 2 O 2 -induced mitochondrial dysfunction J. Toxicol. Sci. 2014 39 803 813 10.2131/jts.39.803 25242411
26. Blade C. Arola L. Salvado M.J. Hypolipidemic effects of proanthocyanidins and their underlying biochemical and molecular mechanisms Mol. Nutr. Food Res. 2010 54 37 59 10.1002/mnfr.200900476 19960459
27. Karthikeyan K. Bai B.R. Devaraj S.N. Cardioprotective effect of grape seed proanthocyanidins on isoproterenol-induced myocardial injury in rats Int. J. Cardiol. 2007 115 326 333 10.1016/j.ijcard.2006.03.016 16828181
28. Shahat A.A. Cos P. De Bruyne T. Apers S. Hammouda F.M. Ismail S.I. Azzam S. Claeys M. Goovaerts E. Pieters L. Antiviral and antioxidant activity of flavonoids and proanthocyanidins from Crataegus sinaica Planta Med. 2002 68 539 541 10.1055/s-2002-32547 12094299
29. Takeshita M. Ishida Y. Akamatsu E. Ohmori Y. Sudoh M. Uto H. Tsubouchi H. Kataoka H. Proanthocyanidin from blueberry leaves suppresses expression of subgenomic hepatitis C virus RNA J. Biol. Chem. 2009 284 21165 21176 10.1074/jbc.M109.004945 19531480
30. Jin Y.H. Min J.S. Jeon S. Lee J. Kim S. Park T. Park D. Jang M.S. Park C.M. Song J.H. Lycorine, a non-nucleoside RNA dependent RNA polymerase inhibitor, as potential treatment for emerging coronavirus infections Phytomedicine 2021 86 153440 10.1016/j.phymed.2020.153440 33376043
31. Jin Y.H. Jeon S. Lee J. Kim S. Jang M.S. Park C.M. Song J.H. Kim H.R. Kwon S. Anticoronaviral Activity of the Natural Phloroglucinols, Dryocrassin ABBA and Filixic Acid ABA from the Rhizome of Dryopteris crassirhizoma by Targeting the Main Protease of SARS-CoV-2 Pharmaceutics 2022 14 376 10.3390/pharmaceutics14020376 35214108
32. Min J.S. Kwon S. Jin Y.H. SARS-CoV-2 RdRp Inhibitors Selected from a Cell-Based SARS-CoV-2 RdRp Activity Assay System Biomedicines 2021 9 996 10.3390/biomedicines9080996 34440200
33. Haid S. Grethe C. Bankwitz D. Grunwald T. Pietschmann T. Identification of a Human Respiratory Syncytial Virus Cell Entry Inhibitor by Using a Novel Lentiviral Pseudotype System J. Virol. 2015 90 3065 3073 10.1128/JVI.03074-15 26719246
34. Chen R.H. Yang L.J. Hamdoun S. Chung S.K. Lam C.W. Zhang K.X. Guo X. Xia C. Law B.Y.K. Wong V.K.W. 1,2,3,4,6-Pentagalloyl Glucose, a RBD-ACE2 Binding Inhibitor to Prevent SARS-CoV-2 Infection Front. Pharmacol. 2021 12 634176 10.3389/fphar.2021.634176 33897423
35. Zhang T. Lo C.Y. Xiao M. Cheng L. Pun Mok C.K. Shaw P.C. Anti-influenza virus phytochemicals from Radix Paeoniae Alba and characterization of their neuraminidase inhibitory activities J. Ethnopharmacol. 2020 253 112671 10.1016/j.jep.2020.112671 32081739
36. Li H. Xu F. Liu C. Cai A. Dain J.A. Li D. Seeram N.P. Cho B.P. Ma H. Inhibitory Effects and Surface Plasmon Resonance-Based Binding Affinities of Dietary Hydrolyzable Tannins and Their Gut Microbial Metabolites on SARS-CoV-2 Main Protease J. Agric. Food Chem. 2021 69 12197 12208 10.1021/acs.jafc.1c03521 34586788
37. Wang Y. Fang S. Wu Y. Cheng X. Zhang L.K. Shen X.R. Li S.Q. Xu J.R. Shang W.J. Gao Z.B. Discovery of SARS-CoV-2-E channel inhibitors as antiviral candidates Acta Pharmacol. Sin. 2022 43 781 787 10.1038/s41401-021-00732-2 34294887
38. Zhu Y. Xie D.Y. Docking Characterization and in vitro Inhibitory Activity of Flavan-3-ols and Dimeric Proanthocyanidins against the Main Protease Activity of SARS-CoV-2 Front. Plant Sci. 2020 11 601316 10.3389/fpls.2020.601316 33329667
*원문 PDF 파일 및 링크정보가 존재하지 않을 경우 KISTI DDS 시스템에서 제공하는 원문복사서비스를 사용할 수 있습니다.
오픈액세스 학술지에 출판된 논문
※ AI-Helper는 부적절한 답변을 할 수 있습니다.